Literature DB >> 29382756

Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma.

Qiumin Tan1,2, Lorenzo Brunetti3,4,5, Maxime W C Rousseaux6,2, Hsiang-Chih Lu6,7, Ying-Wooi Wan6,2, Jean-Pierre Revelli6, Zhandong Liu6,8, Margaret A Goodell2,3,4,8,9, Huda Y Zoghbi1,2,7,8,10.   

Abstract

Capicua (CIC) regulates a transcriptional network downstream of the RAS/MAPK signaling cascade. In Drosophila, CIC is important for many developmental processes, including embryonic patterning and specification of wing veins. In humans, CIC has been implicated in neurological diseases, including spinocerebellar ataxia type 1 (SCA1) and a neurodevelopmental syndrome. Additionally, we and others have reported mutations in CIC in several cancers. However, whether CIC is a tumor suppressor remains to be formally tested. In this study, we found that deletion of Cic in adult mice causes T cell acute lymphoblastic leukemia/lymphoma (T-ALL). Using hematopoietic-specific deletion and bone marrow transplantation studies, we show that loss of Cic from hematopoietic cells is sufficient to drive T-ALL. Cic-null tumors show up-regulation of the KRAS pathway as well as activation of the NOTCH1 and MYC transcriptional programs. In sum, we demonstrate that loss of CIC causes T-ALL, establishing it as a tumor suppressor for lymphoid malignancies. Moreover, we show that mouse models lacking CIC in the hematopoietic system are robust models for studying the role of RAS signaling as well as NOTCH1 and MYC transcriptional programs in T-ALL.

Entities:  

Keywords:  Capicua; MYC transcriptional program; NOTCH activation; T cell development; T-ALL

Mesh:

Substances:

Year:  2018        PMID: 29382756      PMCID: PMC5816173          DOI: 10.1073/pnas.1716452115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

Review 1.  Launching the T-cell-lineage developmental programme.

Authors:  Ellen V Rothenberg; Jonathan E Moore; Mary A Yui
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

2.  Capicua DNA-binding sites are general response elements for RTK signaling in Drosophila.

Authors:  Leiore Ajuria; Claudia Nieva; Clint Winkler; Dennis Kuo; Núria Samper; María José Andreu; Aharon Helman; Sergio González-Crespo; Ze'ev Paroush; Albert J Courey; Gerardo Jiménez
Journal:  Development       Date:  2011-01-26       Impact factor: 6.868

3.  ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.

Authors:  Yung C Lam; Aaron B Bowman; Paymaan Jafar-Nejad; Janghoo Lim; Ronald Richman; John D Fryer; Eric D Hyun; Lisa A Duvick; Harry T Orr; Juan Botas; Huda Y Zoghbi
Journal:  Cell       Date:  2006-12-29       Impact factor: 41.582

4.  CIC-rearranged Sarcomas: A Study of 20 Cases and Comparisons With Ewing Sarcomas.

Authors:  Akihiko Yoshida; Keisuke Goto; Makoto Kodaira; Eisuke Kobayashi; Hiroshi Kawamoto; Taisuke Mori; Seiichi Yoshimoto; Otone Endo; Narihito Kodama; Ryoji Kushima; Nobuyoshi Hiraoka; Toru Motoi; Akira Kawai
Journal:  Am J Surg Pathol       Date:  2016-03       Impact factor: 6.394

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.

Authors:  Vincent Gleize; Agusti Alentorn; Léa Connen de Kérillis; Marianne Labussière; Aravidan A Nadaradjane; Emeline Mundwiller; Chris Ottolenghi; Stephanie Mangesius; Amithys Rahimian; François Ducray; Karima Mokhtari; Chiara Villa; Marc Sanson
Journal:  Ann Neurol       Date:  2015-07-27       Impact factor: 10.422

7.  Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.

Authors:  Yin P Hung; Christopher Dm Fletcher; Jason L Hornick
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

8.  Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia.

Authors:  Daniel Herranz; Alberto Ambesi-Impiombato; Jessica Sudderth; Marta Sánchez-Martín; Laura Belver; Valeria Tosello; Luyao Xu; Agnieszka A Wendorff; Mireia Castillo; J Erika Haydu; Javier Márquez; José M Matés; Andrew L Kung; Stephen Rayport; Carlos Cordon-Cardo; Ralph J DeBerardinis; Adolfo A Ferrando
Journal:  Nat Med       Date:  2015-09-21       Impact factor: 53.440

9.  Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Etienne Danis; Taylor Yamauchi; Kristen Echanique; Xi Zhang; Jessica N Haladyna; Simone S Riedel; Nan Zhu; Huafeng Xie; Stuart H Orkin; Scott A Armstrong; Kathrin M Bernt; Tobias Neff
Journal:  Cell Rep       Date:  2016-02-18       Impact factor: 9.423

10.  BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis.

Authors:  Frederik Otzen Bagger; Damir Sasivarevic; Sina Hadi Sohi; Linea Gøricke Laursen; Sachin Pundhir; Casper Kaae Sønderby; Ole Winther; Nicolas Rapin; Bo T Porse
Journal:  Nucleic Acids Res       Date:  2015-10-26       Impact factor: 16.971

View more
  17 in total

1.  Capicua restricts cancer stem cell-like properties in breast cancer cells.

Authors:  Jeehyun Yoe; Donghyo Kim; Sanguk Kim; Yoontae Lee
Journal:  Oncogene       Date:  2020-02-27       Impact factor: 9.867

Review 2.  The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.

Authors:  Lucía Simón-Carrasco; Gerardo Jiménez; Mariano Barbacid; Matthias Drosten
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

3.  ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.

Authors:  Maxime W C Rousseaux; Tyler Tschumperlin; Hsiang-Chih Lu; Elizabeth P Lackey; Vitaliy V Bondar; Ying-Wooi Wan; Qiumin Tan; Carolyn J Adamski; Jillian Friedrich; Kirk Twaroski; Weili Chen; Jakub Tolar; Christine Henzler; Ajay Sharma; Aleksandar Bajić; Tao Lin; Lisa Duvick; Zhandong Liu; Roy V Sillitoe; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2018-03-08       Impact factor: 17.173

Review 4.  ERK signalling: a master regulator of cell behaviour, life and fate.

Authors:  Hugo Lavoie; Jessica Gagnon; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2020-06-23       Impact factor: 94.444

5.  Noncanonical function of Capicua as a growth termination signal in Drosophila oogenesis.

Authors:  Laura Rodríguez-Muñoz; Clàudia Lagares; Sergio González-Crespo; Pau Castel; Alexey Veraksa; Gerardo Jiménez
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-26       Impact factor: 12.779

Review 6.  Small round cell sarcomas.

Authors:  Florencia Cidre-Aranaz; Sarah Watson; James F Amatruda; Takuro Nakamura; Olivier Delattre; Enrique de Alava; Uta Dirksen; Thomas G P Grünewald
Journal:  Nat Rev Dis Primers       Date:  2022-10-06       Impact factor: 65.038

7.  CIC is a critical regulator of neuronal differentiation.

Authors:  Inah Hwang; Heng Pan; Jun Yao; Olivier Elemento; Hongwu Zheng; Jihye Paik
Journal:  JCI Insight       Date:  2020-05-07

8.  Morphologic and Immunohistochemical Characterization of Spontaneous Lymphoma/Leukemia in NSG Mice.

Authors:  Heather Tillman; Laura J Janke; Amy Funk; Peter Vogel; Jerold E Rehg
Journal:  Vet Pathol       Date:  2019-11-18       Impact factor: 2.221

9.  The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.

Authors:  Simon Weissmann; Paul A Cloos; Simone Sidoli; Ole N Jensen; Steven Pollard; Kristian Helin
Journal:  Cancer Res       Date:  2018-05-29       Impact factor: 12.701

Review 10.  Capicua in Human Cancer.

Authors:  Ji Won Kim; Rovingaile Kriska Ponce; Ross A Okimoto
Journal:  Trends Cancer       Date:  2020-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.